HKD 25.2
(2.86%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 170.9 Million USD | 21.19% |
2022 | 141.02 Million USD | 53.16% |
2021 | 92.07 Million USD | 185.75% |
2020 | 32.22 Million USD | 248.88% |
2019 | 9.23 Million USD | 10656.73% |
2018 | 85.86 Thousand USD | 0.0% |
2017 | - USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 65.27 Million USD | 21.93% |
2024 Q1 | 53.53 Million USD | 31.87% |
2023 Q3 | 43.74 Million USD | -3.0% |
2023 Q2 | 45.1 Million USD | 8.78% |
2023 FY | 170.9 Million USD | 21.19% |
2023 Q1 | 41.46 Million USD | -0.52% |
2023 Q4 | 40.59 Million USD | -7.21% |
2022 Q1 | 31.08 Million USD | 38.34% |
2022 FY | 141.02 Million USD | 53.16% |
2022 Q4 | 41.67 Million USD | 11.15% |
2022 Q3 | 37.49 Million USD | 21.86% |
2022 Q2 | 30.76 Million USD | -1.0% |
2021 FY | 92.07 Million USD | 185.75% |
2021 Q2 | 26.06 Million USD | 106.91% |
2021 Q3 | 30.94 Million USD | 18.7% |
2021 Q4 | 22.46 Million USD | -27.39% |
2021 Q1 | 12.59 Million USD | 52.3% |
2020 Q2 | 8.09 Million USD | 32.03% |
2020 Q3 | 9.71 Million USD | 19.98% |
2020 FY | 32.22 Million USD | 248.88% |
2020 Q4 | 8.27 Million USD | -14.87% |
2020 Q1 | 6.13 Million USD | 99.81% |
2019 Q2 | 1.26 Million USD | 0.0% |
2019 FY | 9.23 Million USD | 10656.73% |
2019 Q4 | 3.06 Million USD | -15.37% |
2019 Q3 | 3.62 Million USD | 185.86% |
2019 Q1 | 1.26 Million USD | 1377.95% |
2018 Q1 | - USD | 0.0% |
2018 Q2 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | 85.86 Thousand USD | 0.0% |
2018 FY | 85.86 Thousand USD | 0.0% |
2017 FY | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2015 FY | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | 56.493% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 81.967% |